Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| High Mobility Group Proteins | 2 | 2015 | 44 | 0.880 |
Why?
|
| Transcriptional Elongation Factors | 2 | 2015 | 40 | 0.870 |
Why?
|
| Paraproteins | 1 | 2021 | 3 | 0.720 |
Why?
|
| Hematologic Tests | 1 | 2021 | 22 | 0.710 |
Why?
|
| Immunoassay | 1 | 2021 | 113 | 0.670 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 2015 | 404 | 0.670 |
Why?
|
| Chromatography, Gas | 1 | 2020 | 33 | 0.660 |
Why?
|
| src-Family Kinases | 4 | 2009 | 92 | 0.640 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2015 | 556 | 0.640 |
Why?
|
| Immunoglobulin A | 1 | 2021 | 210 | 0.630 |
Why?
|
| Multiple Myeloma | 1 | 2021 | 251 | 0.560 |
Why?
|
| DNA-Binding Proteins | 2 | 2015 | 1501 | 0.520 |
Why?
|
| Ethanol | 1 | 2020 | 606 | 0.470 |
Why?
|
| Nucleosomes | 1 | 2015 | 155 | 0.420 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2020 | 434 | 0.420 |
Why?
|
| Molecular Chaperones | 1 | 2013 | 195 | 0.350 |
Why?
|
| Blood Glucose | 1 | 2021 | 2181 | 0.350 |
Why?
|
| Histones | 1 | 2015 | 636 | 0.330 |
Why?
|
| Transcription Factors | 2 | 2015 | 1718 | 0.330 |
Why?
|
| Reactive Oxygen Species | 2 | 2009 | 621 | 0.320 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2009 | 66 | 0.300 |
Why?
|
| Cysteine | 1 | 2009 | 204 | 0.280 |
Why?
|
| Crystallography, X-Ray | 2 | 2015 | 476 | 0.200 |
Why?
|
| Conserved Sequence | 2 | 2015 | 239 | 0.180 |
Why?
|
| False Positive Reactions | 1 | 2021 | 115 | 0.170 |
Why?
|
| Glycols | 1 | 2020 | 7 | 0.170 |
Why?
|
| AAA Domain | 1 | 2020 | 3 | 0.170 |
Why?
|
| Ethylene Glycol | 1 | 2020 | 13 | 0.160 |
Why?
|
| Calibration | 1 | 2020 | 146 | 0.160 |
Why?
|
| Quality Control | 1 | 2020 | 171 | 0.160 |
Why?
|
| Reference Standards | 1 | 2020 | 186 | 0.160 |
Why?
|
| Drug Monitoring | 1 | 2020 | 218 | 0.140 |
Why?
|
| Phosphorylation | 4 | 2020 | 1758 | 0.140 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2020 | 234 | 0.140 |
Why?
|
| Structure-Activity Relationship | 2 | 2020 | 570 | 0.130 |
Why?
|
| Oxidation-Reduction | 2 | 2009 | 1059 | 0.120 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2015 | 72 | 0.120 |
Why?
|
| Amino Acid Motifs | 1 | 2015 | 225 | 0.120 |
Why?
|
| Sequence Alignment | 1 | 2015 | 342 | 0.120 |
Why?
|
| Protein Binding | 3 | 2020 | 2216 | 0.110 |
Why?
|
| Protein Multimerization | 1 | 2015 | 191 | 0.110 |
Why?
|
| Structural Homology, Protein | 1 | 2013 | 27 | 0.100 |
Why?
|
| Molecular Sequence Data | 2 | 2015 | 2894 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 2 | 2013 | 860 | 0.100 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 3265 | 0.090 |
Why?
|
| Protein Structure, Secondary | 1 | 2013 | 374 | 0.090 |
Why?
|
| Models, Molecular | 1 | 2015 | 1570 | 0.080 |
Why?
|
| Humans | 8 | 2021 | 136765 | 0.080 |
Why?
|
| Signal Transduction | 3 | 2020 | 5076 | 0.080 |
Why?
|
| Catalysis | 2 | 2006 | 307 | 0.080 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2006 | 374 | 0.080 |
Why?
|
| Histidine | 1 | 2006 | 64 | 0.070 |
Why?
|
| Recombinant Proteins | 2 | 2006 | 1350 | 0.060 |
Why?
|
| Kinetics | 2 | 2006 | 1664 | 0.060 |
Why?
|
| Amino Acid Substitution | 1 | 2006 | 306 | 0.060 |
Why?
|
| Plasmids | 1 | 2006 | 360 | 0.060 |
Why?
|
| Amino Acid Sequence | 2 | 2006 | 2138 | 0.060 |
Why?
|
| Substrate Specificity | 1 | 2006 | 371 | 0.060 |
Why?
|
| Animals | 3 | 2013 | 36847 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2006 | 664 | 0.050 |
Why?
|
| Catalytic Domain | 2 | 2020 | 207 | 0.050 |
Why?
|
| Escherichia coli | 1 | 2006 | 806 | 0.050 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2020 | 27 | 0.040 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2020 | 15 | 0.040 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2020 | 53 | 0.040 |
Why?
|
| Dimerization | 1 | 2020 | 198 | 0.040 |
Why?
|
| Middle Aged | 1 | 2021 | 33228 | 0.040 |
Why?
|
| Tyrosine | 1 | 2020 | 222 | 0.040 |
Why?
|
| Laboratories | 1 | 2020 | 112 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2020 | 810 | 0.040 |
Why?
|
| Ligands | 1 | 2020 | 661 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2020 | 933 | 0.030 |
Why?
|
| Male | 1 | 2021 | 67311 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-yes | 1 | 2006 | 3 | 0.020 |
Why?
|
| src Homology Domains | 1 | 2006 | 41 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2006 | 385 | 0.010 |
Why?
|
| MAP Kinase Signaling System | 1 | 2006 | 320 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2006 | 622 | 0.010 |
Why?
|
| Binding Sites | 1 | 2006 | 1301 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 2052 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 3405 | 0.010 |
Why?
|
| Time Factors | 1 | 2006 | 6808 | 0.010 |
Why?
|
| Mutation | 1 | 2006 | 3946 | 0.010 |
Why?
|